/images/logo_en.svg
advantan ointment 0.1% 30gr /TR/#1
advantan ointment 0.1% 30gr /TR/#1

advantan ointment 0.1% 30gr /TR/#1

Turkey

აბდი იბრაჰიმი

It is used in adults and in children over 4 months of age for skin conditions that are responsive to treatment with topical glucocorticosteroids.

About Product

Advantan Ointment 0.1% – 30g Tube

Indications:

Ointment, Cream, and Fatty Ointment:
For the treatment of skin conditions (including chronic forms) in adults and children over 4 months of age, which are responsive to topical glucocorticosteroid therapy:

  • Atopic dermatitis, neurodermatitis

  • True eczema

  • Contact dermatitis

  • Dyshidrotic eczema

  • Microbial eczema

  • Degenerative eczema


Topical Emulsion:
In adults and children over 4 months of age – for acute skin conditions:

  • Atopic dermatitis, neurodermatitis

  • Contact dermatitis

  • True eczema

  • Seborrheic eczema

  • Dyshidrotic eczema

  • Degenerative eczema

  • Sunburn (solar dermatitis)


Side Effects:

In rare cases, itching, burning, erythema, or the appearance of vesicles at the site of application may occur. Dermatitis and allergic reactions are uncommon.


Storage Conditions and Shelf Life:

Ointment, Cream, and Emulsion: Store at temperatures not exceeding 25°C. Keep out of reach of children. Shelf life: 3 years.

Fatty Ointment: Store at temperatures not exceeding 30°C. Keep out of reach of children. Shelf life: 5 years.

Show More
More Info
Brand
აბდი იბრაჰიმი
Country
Turkey
Generic
methylprednisolone aceponate
Dose
0.1%
Form
მალამო
Packing
ტუბი
Quantity
1
Volume
30გრ
/images/logo_en.svg
fbBlack
instaBlack
linkedBlack
youtubeBlack
tiktokBlack
Contact Us
phoneBlack
(032) 2 71 07 07
emailBlack
digitalsupport@gepha.com
emailBlack
info@gepha.com
footercompany
JSC Gepha, ID 201991229
footerlocation
24A Sulkhan Tsintsadze Street 0160, Tbilisi, Georgia
Download
Application is available on Android and iOS systems
androidAppBlack
iosAppBlack
©2025. GPC. All rights reserved
powered by
eTech
In case of side effects and complaints about the drugs, please contact us by email:pharmacovigilance@gepha.com
menuHome
Home
menuCart
Cart
menuMyPage
My Page
chat